| Date Filed | Type | Description |
| 10/04/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 10/02/2023 |
8-K
| Quarterly results |
| 08/09/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/09/2023 |
8-K
| Quarterly results |
| 07/03/2023 |
SC 13G/A
| Cormorant Global Healthcare Master Fund, LP reports a 7.4% stake in Praxis Precision Medicines, Inc. |
| 06/30/2023 |
SC 13G
| ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 6.2% stake in Praxis Precision Medicines, Inc. |
| 06/30/2023 |
SC 13G
| Venrock Healthcare Capital Partners III, L.P. reports a 9.1% stake in Praxis Precision Medicines, Inc. |
| 06/28/2023 |
SC 13D/A
| Velan Capital Investment Management LP reports a 4% stake in Praxis Precision Medicines, Inc. |
| 06/16/2023 |
8-K
| Termination of a Material Definitive Agreement Interactive Data |
| 06/15/2023 |
FWP
| Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses: |
| 06/15/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 06/09/2023 |
8-K
| Other Events Interactive Data |
| 06/08/2023 |
SC 13G/A
| BlackRock Inc. reports a 4.7% stake in PRAXIS PRECISION MEDICINES, INC. |
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/11/2023 |
8-K
| Quarterly results |
| 04/27/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/17/2023 |
8-K
| Quarterly results |
| 03/21/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/20/2023 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 03/10/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 03/10/2023 |
SC 13G
| Huang James reports a 5.1% stake in Praxis Precision Medicines, Inc. |
| 03/03/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 2.2% stake in Praxis Precision Medicines, Inc. |
| 02/14/2023 |
SC 13G/A
| PFM Health Sciences, LP reports a 5.9% stake in Praxis Precision Medicines, Inc. |
| 02/14/2023 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 7.5% stake in Praxis Precision Medicines, Inc. |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 02/09/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/07/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 02/07/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 02/07/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/07/2023 |
8-K
| Quarterly results |
| 02/07/2023 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 02/02/2023 |
SC 13G
| Avidity Partners Management LP reports a 8.7% stake in Praxis Precision Medicines, Inc. |
|